{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:38:54Z","timestamp":1760254734039},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1007\/bf01271189","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T00:14:36Z","timestamp":1111623276000},"page":"1287-1294","source":"Crossref","is-referenced-by-count":7,"title":["An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa"],"prefix":"10.1007","volume":"103","author":[{"given":"T.","family":"Brannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Prikhojan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Yahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1248\/bpb1978.12.18","volume":"12","author":"H Amano","year":"1989","unstructured":"Amano H, Goshima Y, Akema N, Ueda H, Kubo T, Misu Y (1989) Effects of acute nicotine on catecholamine turnover in various rat brain regions. J Pharmacobio-Dyn 12: 18?23","journal-title":"J Pharmacobio-Dyn"},{"key":"CR2","first-page":"415","volume":"30","author":"H Bernheimer","year":"1975","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1975) Brain dopamine and syndromes of Parkinson and Huntington. J Neurol Sci 30: 415?455","journal-title":"J Neurol Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02251242","volume":"2","author":"T Brannan","year":"1990","unstructured":"Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr MD (1990) Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions. J Neural Transm [P-D Sect] 2: 15?22","journal-title":"J Neural Transm [P-D Sect]"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0028-3908(91)90143-Y","volume":"30","author":"T Brannan","year":"1991","unstructured":"Brannan T, Martinez-Tica J, Yahr MD (1991) Effect of dietary protein on striatal dopamine formation following L-dopa administration: an in vivo study. Neuropharmacology 30: 1125?1127","journal-title":"Neuropharmacology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/WNL.41.4.596","volume":"41","author":"T Brannan","year":"1991","unstructured":"Brannan T, Mart\u00ednez-Tica J, Yahr MD (1991) Effect of long-term L-Dopa administration on striatal extracellular dopamine release. Neurology 41: 596?598","journal-title":"Neurology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01250671","volume":"89","author":"T Brannan","year":"1992","unstructured":"Brannan T, Mart\u00ednez-Tica J, Yahr MD (1992) Changes in body temperature markedly affect striatal dopamine release and metabolism: an in vivo study. J Neural Transm [Gen Sect] 89: 193?196","journal-title":"J Neural Transm [Gen Sect]"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410280412","volume":"28","author":"DJ Brooks","year":"1990","unstructured":"Brooks DJ, Iba\u00f1ez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RSJ (1990) Differing patterns of striatal18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 28: 547?555","journal-title":"Ann Neurol"},{"issue":"Suppl 6","key":"CR8","first-page":"23","volume":"43","author":"TN Chase","year":"1993","unstructured":"Chase TN, Mouradian MM, Engber TM (1993) Motor response complications and the function of striatal efferent systems. Neurology 43 [Suppl 6]: 23?27","journal-title":"Neurology"},{"issue":"Suppl 232","key":"CR9","first-page":"1","volume":"62","author":"A Dahlstr\u00f6m","year":"1965","unstructured":"Dahlstr\u00f6m A, Fuxe K (1965) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand62 [Suppl 232]: 1?55","journal-title":"Acta Physiol Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) in Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 38: 1236?1239","journal-title":"Wien Klin Wochenschr"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JU Fearnley","year":"1991","unstructured":"Fearnley JU, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283?2301","journal-title":"Brain"},{"key":"CR12","first-page":"189","volume":"217","author":"F Hefti","year":"1981","unstructured":"Hefti F, Melamed E, Wurtman RJ (1981) The site of dopamine formation in rat striatum after L-Dopa administration. J Pharmacol Exp Ther 217: 189?197","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(74)90306-3","volume":"15","author":"O Hornykiewicz","year":"1974","unstructured":"Hornykiewicz O (1974) The mechanisms of action of L-Dopa in Parkinson's disease. Life Sci 15: 1249?1259","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-8993(79)90819-9","volume":"167","author":"GP Kaplan","year":"1979","unstructured":"Kaplan GP, Hartmen BY, Cerveling CR (1979) Immunohistochemical demonstration of catechol-o-methyltransferase in mammalian brain. Brain Res 167: 241?250","journal-title":"Brain Res"},{"key":"CR15","first-page":"453","volume":"195","author":"KG Lloyd","year":"1975","unstructured":"Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther 195: 453?464","journal-title":"J Pharmacol Exp Ther"},{"key":"CR16","first-page":"87","volume-title":"Parkinson's disease and movement disorders","author":"E Melamed","year":"1988","unstructured":"Melamed E (1988) Mechanism of action of exogenous L-Dopa. Is it a physiological therapy for Parkinson's disease? In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders. Urban & Schwarzenberg, Baltimore, pp 87?94"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/283772a0","volume":"283","author":"E Melamed","year":"1980","unstructured":"Melamed E, Hefti F, Liebman J, Schlosberg AJ, Wurtman RJ (1980) Serotonergic neurones are not involved in action of L-Dopa in Parkinson's disease. Nature 283: 772?774","journal-title":"Nature"},{"key":"CR18","first-page":"427","volume-title":"Parkinson's disease","author":"P Morrish","year":"1996","unstructured":"Morrish P, Sawle GV, Brooks DJ (1996) The rate of progression of Parkinson's disease: a longitudinal [18F]DOPA PET study. In: Battistin L, Scarloto G, Caraceni T, Ruggieri S (eds) Parkinson's disease. Lippincott-Raven, Philadelphia, pp 427?431 (Adv Neurol, vol 69)"},{"key":"CR19","first-page":"103","volume-title":"Parkinson's disease and movement disorders","author":"W Poewe","year":"1993","unstructured":"Poewe W (1993) L-Dopa in Parkinson's disease: new directions for research. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders, 2nd ed. Williams & Wilkins, Baltimore, pp 103?114","edition":"2nd ed."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(77)92153-5","volume":"I","author":"MD Yahr","year":"1977","unstructured":"Yahr MD (1977) Long-term levodopa in Parkinson's disease. Lancet I: 706?707","journal-title":"Lancet"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01271189\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:14:09Z","timestamp":1556633649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01271189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["BF01271189"],"URL":"https:\/\/doi.org\/10.1007\/bf01271189","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}